First patient enrolled in the MuControl study

Ad Scientiam is proud to announce the enrollment of the first patient at the Rouen CRCM (cystic fibrosis resource and competence center) in the clinical validation study of MuCopilot, our innovative remote monitoring solution for patients living with cystic fibrosis.

Developed in collaboration with the French Cystic Fibrosis Society (Société Française de la Mucoviscidose) and other partners, MuCopilot allows patients to perform tests at home via their smartphone while staying in touch with their care teams.